New insights into COVID-19 spike protein offer hope for universal vaccines

A team led by Jose Onuchic at Rice University and Paul Whitford at Northeastern University, both researchers at the National Science Foundation Physics Frontiers Center at the Center for Theoretical Biological Physics (CTBP) at Rice, has made a discovery in the fight against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19.

AbbVie and Neomorph to develop glue degraders

January 24, 2025

NewAmsterdam hits primary endpoint in latest Phase 3 trial of CETP inhibitor

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 11, 2024

Early AMR pipeline looks beyond traditional antibiotics – Pharmaceutical Technology

Share this article Antimicrobial resistance (AMR) has been identified as a major global threat by the WHO. Image Credit: Inkoly / Shutterstock. Despite being tagged

March 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.